Vanguard Group’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $52.1K | Sell |
|
|||||
|
2024
Q4 | $71.1K | Sell |
|
|||||
|
2024
Q3 | $190K | Sell |
|
|||||
|
2024
Q2 | $183K | Sell |
|
|||||
|
2024
Q1 | $263K | Sell |
|
|||||
|
2023
Q4 | $457K | Sell |
|
|||||
|
2023
Q3 | $907K | Buy |
|
|||||
|
2023
Q2 | $789K | Sell |
|
|||||
|
2023
Q1 | $739K | Hold |
|
|||||
|
2022
Q4 | $1.1M | Buy |
|
|||||
|
2022
Q3 | $895K | Buy |
|
|||||
|
2022
Q2 | $1.02M | Buy |
|
|||||
|
2022
Q1 | $918K | Buy |
|
|||||
|
2021
Q4 | $1.35M | Buy |
|
|||||
|
2021
Q3 | $920K | Buy |
|
|||||
|
2021
Q2 | $1.05M | Sell |
|
|||||
|
2021
Q1 | $1.04M | Buy |
|
|||||
|
2020
Q4 | $1.08M | Buy |
|